August 1, 2020:

This month, the Big Ten Cancer Research Consortium highlights Masonic Cancer Center, University of Minnesota, as our featured member. Veronika Bachanova, MD, PhD, shares her research interests, and Jeffrey Miller, MD, discusses his research in natural killer (NK) cells.

Investigator Spotlight

Veronika Bachanova, MD, PhD, professor of medicine, Masonic Cancer Center, University of Minnesota Medical School

Educational background

• Medical School: Komenius University, Bratislava, Slovakia
• Residency: Henry Ford Hospital, Detroit, Mich.
• Fellowship: University of Minnesota, Minneapolis, Minn.

Research interests

I am a professor of medicine at the University of Minnesota, section head of hematologic malignancy, and lead for CAR-T Cell Therapy in the Bone Marrow Transplant Program at University of Minnesota. My research and clinical work is focused on immunotherapies and stem cell transplantation for hematologic malignancies, particularly lymphoma. I founded and currently chair the Hematologic Malignancy Tissue Bank and have designed and conducted dozens of investigator-initiated clinical trials for lymphoma and leukemia. Read More